Latest Platform Providers News

Adherium Limited has reached a pivotal commercial milestone by expanding its Remote Patient Monitoring program across 110 U.S. Allergy Partners clinics, activating nearly 70% of the network and onboarding close to 700 patients in six months.

EVE Health Group has partnered with telehealth provider hubMed to deliver a national patient support program, enhancing care continuity for users of its Dyspro and Libbo therapies.

Megaport Limited has launched a A$200 million equity raising to fund the acquisition of Latitude.sh, a high-growth Compute-as-a-Service platform, and accelerate its network expansion in India. This strategic move aims to unify network and compute services, enhancing Megaport’s position in the hybrid cloud and AI markets.

EVE Health Group has taken significant strides in commercialising its women’s and men’s health products Dyspro™ and Libbo™, securing regulatory clearances, first patient prescriptions, and raising $1.1 million to support market expansion.

Echo IQ Limited has advanced its EchoSolv heart failure solution towards FDA submission, driven by a landmark clinical validation study and a sharp rise in US platform adoption. Strategic partnerships and international expansion efforts underscore the company’s growing footprint in cardiology AI.

Sprintex Limited has landed US$321,000 in new purchase orders from its exclusive Indian distributor Euroteck, following the launch of its advanced GR Series Jet Blowers and a key commissioning at Delhi’s Kondli wastewater plant. This momentum underscores Sprintex’s growing footprint in India’s expanding wastewater treatment market.

Spectur Limited reported a 6% revenue increase to $8.7 million and slashed its net loss by 70% to $779,000 in FY25, driven by operational restructuring and a shift toward recurring revenue streams.

Gratifii Limited has reported a robust FY25 with revenue and transaction values more than doubling, driven by key acquisitions and new product launches. The company is poised for further growth in FY26 with platform upgrades and expanding client partnerships.

Starpharma reports a significant 183% jump in FY25 revenue to $4.9 million, alongside a 31% reduction in losses and a solid cash position of $15.4 million. The biotech firm’s progress underscores growing momentum in its dendrimer technology pipeline.

Resolution Minerals has successfully uplisted to the OTCQB Market in the U.S., enhancing access for American investors without issuing new shares. This move aligns with its strategy to tap into growing demand for critical minerals, particularly antimony.

Qualitas Limited has reported record full-year earnings for FY25, driven by strong growth in funds management revenue and expanding commercial real estate activity. The company has raised its FY26 profit guidance, signalling confidence in continued momentum.

Income Asset Management announces key board retirements and appointments set for November 2025, aiming to strengthen governance and accelerate growth.